RT Journal Article
SR Electronic
T1 Causes of death in mental health service users during the first wave of the COVID-19 pandemic: South London and Maudsley data from March to June 2020, compared with 2015-2019
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.25.20219071
DO 10.1101/2020.10.25.20219071
A1 Stewart, Robert
A1 Jewell, Amelia
A1 Broadbent, Matthew
A1 Bakolis, Ioannis
A1 Das-Munshi, Jayati
YR 2020
UL http://medrxiv.org/content/early/2020/10/27/2020.10.25.20219071.abstract
AB The COVID-19 pandemic is likely to have had a particularly high impact on the health and wellbeing of people with pre-existing mental disorders. This may include higher than expected mortality rates due to severe infections themselves, due to other comorbidities, or through increased suicide rates during lockdown. However, there has been very little published information to date on causes of death in mental health service users. Taking advantage of a large mental healthcare database linked to death registrations, we describe numbers of deaths within specific underlying-cause-of-death groups for the period from 1st March to 30th June in 2020 and compare these with the same four-month periods in 2015-2019. In past and current service users, there were 2561 deaths in March-June 2020, compared to an average of 1452 for the same months in 2015-19: an excess of 1109. The 708 deaths with COVID-19 as the underlying cause in 2020 accounted for 63.8% of that excess. The remaining excess was accounted for by unnatural/unexplained deaths and by deaths recorded as due to neurodegenerative conditions, with no excess in those attributed to cancer, circulatory disorders, digestive disorders, respiratory disorders, or other disease codes. Of 295 unexplained deaths in 2020 with missing data on cause, 162 (54.9%) were awaiting a formal death notice (i.e. the group that included deaths awaiting a coroner’s inquest) – an excess of 129 compared to the average of previous years, accounting for 11.6% of the excess in total deaths.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe research leading to these results has received support from the Medical Research Council Mental Health Data Pathfinder Award to Kings College London, and a grant from Kings Together. RS and MB are part-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at the South London and Maudsley NHS Foundation Trust and Kings College London; RS is additionally part-funded by: i) a Medical Research Council (MRC) Mental Health Data Pathfinder Award to Kings College London; ii) an NIHR Senior Investigator Award; iii) the National Institute for Health Research (NIHR) Applied Research Collaboration South London (NIHR ARC South London) at Kings College Hospital NHS Foundation Trust. JD is funded by the Health Foundation working together with the Academy of Medical Sciences, for a Clinician Scientist Fellowship and by the ESRC in relation to the SEP-MD study (ES/S002715/1) and part supported by the ESRC Centre for Society and Mental Health at Kings College London (ESRC Reference: ES/S012567/1). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the MRC, the Department of Health and Social Care, the ESRC or King's College London.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:CRIS has received approval as a data source for secondary analyses (Oxford Research Ethics Committee C, reference 18/SC/0372).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available on request from the corresponding author.